Literature DB >> 15347661

cAMP-dependent protein kinase regulates ubiquitin-proteasome-mediated degradation and subcellular localization of the nuclear receptor coactivator GRIP1.

Tuyen Hoang1, Ingvild S Fenne, Carol Cook, Bente Børud, Marit Bakke, Ernst Asbjørn Lien, Gunnar Mellgren.   

Abstract

Nuclear receptors and their coactivators are key regulators of numerous physiological functions. GRIP1 (glucocorticoid receptor-interacting protein) is a member of the steroid receptor coactivator family. Here, we show that GRIP1 is regulated by cAMP-dependent protein kinase (PKA) that induces its degradation through the ubiquitin-proteasome pathway. GRIP1 was down-regulated in transiently transfected COS-1 cells after treatment with 8-para-chlorophenylthio-cAMP or forskolin and 3-isobutyl-1-methylxanthine and in adrenocortical Y1 cells after incubation with adrenocorticotropic hormone. Pulse-chase experiments with transiently transfected COS-1 cells demonstrated that the half-life of GRIP1 was markedly reduced in cells overexpressing the PKA catalytic subunit, suggesting that activation of PKA increases the turnover of GRIP1 protein. The proteasome inhibitors MG132 and lactacystin abolished the PKA-mediated degradation of GRIP1. Using ts20 cells, a temperature-sensitive cell line that contains a thermolabile ubiquitin-activating E1 enzyme, it was confirmed that PKA-mediated degradation of GRIP1 is dependent upon the ubiquitin-proteasome pathway. Coimmunoprecipitation studies of COS-1 cells transfected with expression vectors encoding GRIP1 and ubiquitin using anti-GRIP1 and anti-ubiquitin antibodies showed that the ubiquitination of GRIP1 was increased by overexpression of PKA. Finally, we show that PKA regulates the intracellular distribution pattern of green fluorescent protein-GRIP1 and stimulates recruitment of GRIP1 to subnuclear foci that are colocalized with the proteasome. Taken together, these data demonstrate that GRIP1 is ubiquitinated and degraded through activation of the PKA pathway. This may represent a novel regulatory mechanism whereby hormones down-regulate a nuclear receptor coactivator.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15347661     DOI: 10.1074/jbc.M409746200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Reprogramming the posttranslational code of SRC-3 confers a switch in mammalian systems biology.

Authors:  Brian York; Chundong Yu; Jørn V Sagen; Zhaoliang Liu; Bryan C Nikolai; Ray-Chang Wu; Milton Finegold; Jianming Xu; Bert W O'Malley
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-01       Impact factor: 11.205

2.  Ligand-dependent degradation of SRC-1 is pivotal for progesterone receptor transcriptional activity.

Authors:  Larbi Amazit; Audrey Roseau; Junaid A Khan; Anne Chauchereau; Rakesh K Tyagi; Hugues Loosfelt; Philippe Leclerc; Marc Lombès; Anne Guiochon-Mantel
Journal:  Mol Endocrinol       Date:  2011-01-27

3.  Glucocorticoid-dependent phosphorylation of the transcriptional coregulator GRIP1.

Authors:  Jana Dobrovolna; Yurii Chinenov; Megan A Kennedy; Bill Liu; Inez Rogatsky
Journal:  Mol Cell Biol       Date:  2011-12-12       Impact factor: 4.272

4.  Phosphorylation of RGS13 by the cyclic AMP-dependent protein kinase inhibits RGS13 degradation.

Authors:  Zhihui Xie; Zhao Yang; Kirk M Druey
Journal:  J Mol Cell Biol       Date:  2010-10-25       Impact factor: 6.216

Review 5.  Regulatory circuits controlling white versus brown adipocyte differentiation.

Authors:  Jacob B Hansen; Karsten Kristiansen
Journal:  Biochem J       Date:  2006-09-01       Impact factor: 3.857

6.  The activity and stability of the transcriptional coactivator p/CIP/SRC-3 are regulated by CARM1-dependent methylation.

Authors:  Hina Naeem; Donghang Cheng; Qingshi Zhao; Caroline Underhill; Marc Tini; Marc T Bedford; Joseph Torchia
Journal:  Mol Cell Biol       Date:  2006-10-16       Impact factor: 4.272

7.  CARM1 mediates the ligand-independent and tamoxifen-resistant activation of the estrogen receptor alpha by cAMP.

Authors:  Sophie Carascossa; Peter Dudek; Bruno Cenni; Pierre-André Briand; Didier Picard
Journal:  Genes Dev       Date:  2010-04-01       Impact factor: 11.361

8.  Tissue-specific ablation of Prkar1a causes schwannomas by suppressing neurofibromatosis protein production.

Authors:  Georgette N Jones; Chhavy Tep; William H Towns; Georgeta Mihai; Ian D Tonks; Graham F Kay; Petra M Schmalbrock; Anat O Stemmer-Rachamimov; Sung Ok Yoon; Lawrence S Kirschner
Journal:  Neoplasia       Date:  2008-11       Impact factor: 5.715

9.  Genome wide transcriptional profiling in breast cancer cells reveals distinct changes in hormone receptor target genes and chromatin modifying enzymes after proteasome inhibition.

Authors:  H Karimi Kinyamu; Jennifer B Collins; Sherry F Grissom; Pratibha B Hebbar; Trevor K Archer
Journal:  Mol Carcinog       Date:  2008-11       Impact factor: 4.784

Review 10.  Normal and cancer-related functions of the p160 steroid receptor co-activator (SRC) family.

Authors:  Jianming Xu; Ray-Chang Wu; Bert W O'Malley
Journal:  Nat Rev Cancer       Date:  2009-09       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.